Product details

Share this page:
Thumbnail image for 9B19MC076
Simplified Chinese language
Published by:
Ivey Publishing (2019)
Version:
2019-07-31
Revision date:
16-Jan-2020
Length:
17 pages
Data source:
Published sources

Abstract

This is a Simplified Chinese version. In 2018, President of the United States, Donald Trump, criticized the company Pfizer Inc (Pfizer) for increasing drug prices-which had been a strategic move by Pfizer in response to industry-wide challenges. This announcement highlighted the complex dynamics of the pharmaceutical industry and the big challenges that innovative research and development (R&D)-intensive pharmaceutical companies faced. The entire pharmaceutical industry was being challenged by issues such as decreasing global average returns on investment and increased R&D costs. In addition, the company faced increased competition from companies from other industries and from emerging-market companies. Pfizer's chief executive officer needed to determine whether or not these changes marked a turning point for the whole industry.

Teaching and learning

This item is suitable for undergraduate and postgraduate courses.

Topics

Industry analysis; Structured analysis; Data management; Multinational corporations; General management/strategy; International
Location:
Size:
Large
Other setting(s):
2018

Access this item

casecent.re/p/166928
View our pricing guide
or to see prices.

Reviews & usage